Heparinized Saline
Heparinized Saline - Related Videos
02:21
Purification of Viral Integrase Using Heparin Affinity Chromatography
0 Views •
2026
Source: Lopez Jr., M. et al. Detection and Removal of Nuclease Contamination During Purification of Recombinant Prototype Foamy Virus Integrase. J. Vis. Exp. (2017)This video demonstrates the procedure for purifying viral integrase from bacterial nuclease contamination using heparin Sepharose column chromatography followed by SDS-PAGE analysis to confirm protein purity.
10:41
Using a GFP-tagged TMEM184A Construct for Confirmation of Heparin Receptor Identity
0 Views •
Cited by 2 •
2017
A construct encoding TMEM184A with a GFP tag at the carboxy-terminus designed for eukaryotic expression, was employed in assays designed to confirm the identification of TMEM184A as a heparin receptor in vascular cells.
12:27
Polyelectrolyte Complex for Heparin Binding Domain Osteogenic Growth Factor Delivery
0 Views •
Cited by 2 •
2016
Self-assembled polyelectrolyte complexes (PEC) fabricated from heparin and protamine were deposited on alginate beads to entrap and regulate the release of osteogenic growth factors. This delivery strategy enables a 20-fold reduction of BMP-2 dose in spinal fusion applications. This article illustrates the benefits and fabrication of PECs.
03:15
A Hypertonic Saline Injection Technique for Inducing Glaucoma in Rats
0 Views •
2025
This video demonstrates glaucoma induction in an anesthetized rat by injecting hypertonic saline into the episcleral vein. The saline enters the trabecular meshwork via Schlemm's canal, causing tissue scarring, which blocks aqueous humor outflow and raises intraocular pressure. The elevated pressure damages retinal ganglion cells, leading to glaucoma.
01:17
Salinity Tolerance of Alishewanella Species Isolated from Seawall Muddy Water
0 Views •
2025
Begin with a culture of Alishewanella, a Gram-negative, salt-tolerant bacterium.Next, streak the culture onto agar plates containing increasing concentrations of sodium chloride to simulate varying levels of saline stress.Overlay each plate with a layer of unsolidified medium to prevent oxygen diffusion and maintain the culture in an oxygen-limited environment.Seal and incubate the plates at an optimum temperature to support bacterial growth.During incubation, the bacterium exhibits varying...
FAQs
Heparin strengthens the activity of antithrombin, a natural anticoagulant, against thrombin and factor Xa. This reduces the generation of fibrin, the protein that helps stabilize blood clots. Within a catheter or line, limiting fibrin formation helps preserve an open lumen, supporting continued access for blood sampling or medication delivery.
Thrombin and factor Xa participate at important stages of the coagulation process. Heparin-mediated enhancement of antithrombin inhibition reduces their activity and therefore decreases fibrin generation. This mechanism explains why even a small amount of heparin in a flush solution can be relevant to maintaining vascular-device patency, although the intended concentration must follow clinical protocol.
Concentration and volume determine how much heparin is introduced while the device is flushed. Incorrect selection could compromise the intended catheter-patency strategy or create avoidable patient-safety concerns. For that reason, clinicians should use the concentration and volume specified by the applicable institutional protocol rather than treating all vascular devices or patients identically.
The distinguishing feature is the added anticoagulant mechanism. Heparinized saline can enhance antithrombin inhibition of thrombin and factor Xa, thereby reducing fibrin generation during flushing. The overview does not establish that one approach is universally preferable; device type, institutional policy, concentration, volume, and patient-safety considerations determine which flushing strategy is appropriate.
Clinical use begins with selecting the solution concentration and flush volume required by the institutional protocol for the specific access device. The sterile solution is then used as a flush to help maintain the device lumen. Careful management of these parameters supports reliable access while keeping the procedure aligned with patient-safety requirements.
Potential applications include arterial lines, central venous catheters, and other intravascular devices. In these settings, maintaining lumen patency can support dependable blood sampling and medication delivery. The appropriate use is not determined by the device name alone, because institutional protocols specify when heparinized saline is used and what concentration or volume is required.